The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

Solomon, Scott D, Prof Dr ; Zile, Michael, Prof ; Pieske, Burkert, Prof ; Voors, Adriaan, Prof ; Shah, Amil, MD ; Kraigher-Krainer, Elisabeth, MD ; Shi, Victor, MD ; Bransford, Toni, MD ; Takeuchi, Madoka, MS ; Gong, Jianjian, PhD ; Lefkowitz, Martin, MD ; Packer, Milton, Prof ; McMurray, John JV, Prof

The Lancet (British edition), 2012-10, Vol.380 (9851), p.1387-1395 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available